Low-dose prednisolone eases long-COVID symptoms modestly, but B vitamins fail in phase 3 trial
In the first randomised placebo-controlled phase 3 factorial trial for post-COVID-19 syndrome, a 28-day course of low-dose prednisolone significantly reduced ...
